Home › NDC Lookup › RxCUI directory › RxCUI 2260704

0.6 ML pegfilgrastim-bmez 10 MG/ML Prefilled Syringe — RxCUI 2260704

Name: 0.6 ML pegfilgrastim-bmez 10 MG/ML Prefilled Syringe (RxCUI 2260704)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2260704 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2260704

Official name0.6 ML pegfilgrastim-bmez 10 MG/ML Prefilled Syringe

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known aspegfilgrastim-bmez 6 MG per 0.6 ML Prefilled Syringe; pegfilgrastim-bmez 6 MG in 0.6 ML Prefilled Syringe; pegfilgrastim-bmez 10 MG/ML per 0.6 ML Prefilled Syringe

FDA products mapped1

Package NDCs mapped1

Reported Medicaid activity (SDUD)32 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pegfilgrastim Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Chemotherapy works by targeting fast-growing cells — but that includes the cells in your bone marrow that make white blood cells. When white blood cell counts drop too low, your bo...
Why do I need this injection if I'm already getting chemotherapy?
It's given as a shot just under the skin — subcutaneously. Depending on the product and your situation, you might receive it via a manual prefilled syringe, or with the Neulasta on...
The most common side effects are bone pain and aching in your arms and legs — your bones are working harder to produce white blood cells, so some discomfort is normal. But call you...

📖 Read our full Pegfilgrastim Injection guide →

🕸️ Concept Web — How 0.6 ML pegfilgrastim-bmez 10 MG/ML Prefilled Syr... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 0.6 ML pegfilgrastim-bmez 10 MG/ML Prefilled Syringe RxCUI 2260704 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Pegfilgrastim 338036 IN
- Pegfilgrastim-bmez 2260702 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Ziextenzo 2260705 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Pegfilgrastim Prefilled Syringe 727538 SCDF
- Pegfilgrastim-bmez Prefilled Syringe 2647170 SCDFP
- Pegfilgrastim Injectable Product 1161380 SCDG
- Pegfilgrastim-bmez Injectable Product 2660360 SCDGP
- Pegfilgrastim Prefilled Syringe [Ziextenzo] 2260707 SBDF
- Pegfilgrastim-bmez Prefilled Syringe [Ziextenzo] 2655636 SBDFP
- Ziextenzo Injectable Product 2260708 SBDG
- Prefilled Syringe 721656 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Pegfilgrastim-bmez 10 MG/ML 2260703 SCDC
- 0.6 ML pegfilgrastim-bmez 10 MG/ML Prefilled Syringe [Ziextenzo] 2260709 SBD
- Pegfilgrastim-bmez 10 MG/ML [Ziextenzo] 2260706 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Pegfilgrastim-bmez 10 MG/ML SCDC · 2260703
Pegfilgrastim Prefilled Syringe SCDF · 727538
Pegfilgrastim-bmez Prefilled Syringe SCDFP · 2647170
Pegfilgrastim Injectable Product SCDG · 1161380
Pegfilgrastim-bmez Injectable Product SCDGP · 2660360

Brand-Name Concepts

0.6 ML pegfilgrastim-bmez 10 MG/ML Prefilled Syringe [Ziextenzo] SBD · 2260709
Pegfilgrastim-bmez 10 MG/ML [Ziextenzo] SBDC · 2260706
Pegfilgrastim Prefilled Syringe [Ziextenzo] SBDF · 2260707
Pegfilgrastim-bmez Prefilled Syringe [Ziextenzo] SBDFP · 2655636
Ziextenzo Injectable Product SBDG · 2260708
Ziextenzo BN · 2260705

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 2260704 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
61314-0866-02	1 BLISTER PACK in 1 CARTON (61314-866-02) / 1 SYRINGE in 1...	ZIEXTENZO	Sandoz Inc	2025-03-03

Observed labelers: Sandoz Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
Q5120	Inj pegfilgrastim-bmez 0.5mg	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.